1st Quarter - Report

CROSSROADS STRATEGIES, LLC for NOVAVAX, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to COVID-19 vaccines. Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers. General discussions related to vaccine injury compensation programs and vaccine strain selection timelines.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L.119-4); H.Con.Res.14, FY2025 Budget Resolution; FY2025 Budget Reconciliation Process; all bio-pharmaceutical related provisions.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1968 (119th), H.Con.Res. 14 (119th)

Trade (domestic/foreign) TRD

Issues related to tariffs.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.